Healthcare Services Group, Inc.

Valuation Analysis

About the Company

Healthcare Services Group, Inc. en bref

Healthcare Services Group, Inc. (HCSG) is currently trading at 20,00 € with a market capitalization of 1,4 Md €. The trailing P/E ratio stands at 24.15x, with a forward P/E of 19.84x. The 52-week range spans from 11,04 € to 21,26 €; the current price is 5.9% below the yearly high. Year-over-year revenue growth stands at +3.4%. The net profit margin stands at 3.67%.

💰 Dividende

Healthcare Services Group, Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

5 analystes évaluent Healthcare Services Group, Inc. (HCSG) au consensus : None. L'objectif de cours moyen est de 22,84 €, soit un potentiel de +14.21% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 20,92 € à 26,15 €.

Healthcare Services Group, Inc. : la thèse d'investissement en détail

Healthcare Services Group, Inc. (HCSG) operates in the Healthcare — specifically Medical Care Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Earnings growth of 60.9% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base.

Le scénario baissier

Revenue growth has slowed to just 3.4%, which is below nominal GDP — the business is no longer outgrowing the broader economy. With a net margin of just 3.67%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss.

Valorisation en contexte

The PEG ratio at 1.36 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric.

À surveiller

• The forward P/E of 19.84x is meaningfully below the trailing 24.15x — analysts expect earnings to step up; the next earnings release is the test.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

The data points to relatively defensive market behavior.

Trading Data

Related Stocks in the Same Sector

Where can I buy Healthcare Services Group, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.